{"id":981153,"date":"2026-07-13T16:49:07","date_gmt":"2026-07-13T20:49:07","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\/"},"modified":"2026-07-13T16:49:07","modified_gmt":"2026-07-13T20:49:07","slug":"dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\/","title":{"rendered":"Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwblockalignl { margin-left: 0px; margin-right: auto }\n.bwcellpmargin { margin-bottom: 0px; margin-top: 0px }\n.bwlistdisc { list-style-type: disc }\n.bwpadl0 { padding-left: 0px }\n.bwtablemarginb { margin-bottom: 10px }\n.bwuline { text-decoration: underline }\n.bwvertalignt { vertical-align: top }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes<\/b><\/p>\n<p class=\"bwalignc\"><i>Dexcom G7 15 Day is the longest\u2011lasting and most accurate<sup>1-4 <\/sup>CGM system authorized by Health Canada, providing real-time glucose readings for an industry-leading 15.5 days<sup>5.<\/sup><\/i><\/p>\n<p>BURNABY, British Columbia&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nDexcom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) for people 18 years and older living with diabetes.<\/p>\n<p id=\"news-body-cta\">This press release features multimedia. View the full release here: <a href=\"https:\/\/www.businesswire.com\/news\/home\/20260713940133\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260713940133\/en\/<\/a><\/p>\n<div id=\"bwbodyimg\" style=\"width: 480px;float:left;padding-left:0px;padding-right:20px;padding-top:0px;padding-bottom:0px\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260713940133\/en\/2850555\/4\/25.05.26_Dexcom_Day_030483_V2_%281%29.jpg\" alt=\"Dexcom G7 15 Day receives Health Canada authorization. Compatible smart devices sold separately. For a list of compatible devices, see dexcom.com\/compatibility.\" \/><\/p>\n<p style=\"font-size:85%\">Dexcom G7 15 Day receives Health Canada authorization. Compatible smart devices sold separately. For a list of compatible devices, see dexcom.com\/compatibility.<\/p>\n<\/div>\n<p>\nDexcom G7 15 Day is the longest\u2011lasting and most accurate<sup>1-4<\/sup> CGM system authorized by Health Canada, providing real\u2011time glucose readings for an industry\u2011leading 15.5 days<sup>5<\/sup>. Building on the performance of Dexcom CGM which is clinically proven to lower A1C and increase time in range<sup>6-10<\/sup>, Dexcom G7 15 Day sets a new standard in CGM technology that\u2019s easy to use, painless to insert* and requires fewer sensor changes per month.<\/p>\n<p>\nDiabetes is a complex and challenging condition that affects more than four million Canadians<sup>11<\/sup> and requires around-the-clock management of glucose levels and decision\u2011making to manage safely.<\/p>\n<p>\n\u201cSmall improvements can make a meaningful difference for people living with diabetes. Dexcom G7 15 Day reflects our ongoing commitment to simpler, more seamless diabetes management,\u201d said Andr\u00e9 C\u00f4t\u00e9, Vice President and General Manager, Dexcom Canada.<\/p>\n<p><b>New with Dexcom G7 15 Day:<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li>\nLongest lasting CGM system with 15.5 days of wear.<sup>5<\/sup><\/li>\n<li>\nBest-in-class accuracy with an overall MARD of 8.0%.<sup>1-4<\/sup><\/li>\n<li>\nEasier glucose management with fewer monthly sensor changes and reduced waste.<\/p>\n<\/li>\n<\/ul>\n<p><b>Dexcom G7 features included with Dexcom G7 15 Day:<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li>\nThe only waterproof<sup>\u2020<\/sup> CGMs available<\/p>\n<\/li>\n<li>\nDirect to Apple Watch<sup>\u2021<\/sup> connectivity, so you can leave your phone behind and still see your glucose numbers.<\/p>\n<\/li>\n<li>\n12-hour grace period to replace finished sensors for a more seamless transition between sessions.<\/p>\n<\/li>\n<li>\nInnovative and simple mobile app with Dexcom Clarity integration to easily view glucose patterns, trends and statistics for meaningful conversations with your healthcare provider.<sup>\u00a7<\/sup><\/li>\n<li>\nAbility to remotely share glucose numbers with caregivers and loved ones for added support and peace of mind. <sup>||,12<\/sup><\/li>\n<li>\nCustomizable alert settings for improved discretion and personalized diabetes management.<\/p>\n<\/li>\n<\/ul>\n<p>\nWhile authorized by Health Canada, Dexcom G7 15 Day is not yet available for purchase. Andr\u00e9 C\u00f4t\u00e9 shares, \u201cOur focus is on ensuring that when the product becomes available, Canadians living with diabetes and their healthcare providers have the support, education, and experience they need from day one. We look forward to sharing more details as we move closer to availability.\u201d<\/p>\n<p>\nVisit Dexcom.com to get started with Dexcom G7 today, and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.dexcom.com%2Fen-ca%2Fdexcom-g7-15-day&amp;esheet=54569642&amp;newsitemid=20260713940133&amp;lan=en-US&amp;anchor=register+your+details+to+opt+in&amp;index=1&amp;md5=e7d0786239029fa76a5d6081142a60b5\">register your details to opt in<\/a> and receive information when Dexcom G7 15 Day becomes available.<\/p>\n<p><b><span class=\"bwuline\">About Dexcom<\/span><\/b><\/p>\n<p>\nDexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in continuous glucose monitoring for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.<\/p>\n<p>\nDexcom. Discover what you\u2019re made of. For more information, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.dexcom.com&amp;esheet=54569642&amp;newsitemid=20260713940133&amp;lan=en-US&amp;anchor=www.dexcom.com&amp;index=2&amp;md5=4714df376108ebb6853221f7dc0a1c39\">www.dexcom.com<\/a>.<\/p>\n<p>\nCategory: IR<\/p>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignl\">\n<tr>\n<td class=\"bwvertalignt bwpadl0\" rowspan=\"1\" colspan=\"1\">\n<p class=\"bwcellpmargin\">\n____________________<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<p>\n* 96% of patients reported mild\/no pain.<\/p>\n<p>\n\u2020 The Dexcom G7 Sensor is waterproof and may be submerged under eight feet of water for up to 24 hours without failure when properly installed.<\/p>\n<p>\n\u2021 Smart devices sold separately. To view a list of compatible devices, visit dexcom.com\/compatibility. Compatible smartphone is required to pair a new Dexcom G7 sensor with a compatible Apple Watch.<\/p>\n<p>\n\u00a7 An internet connection is required for users to send their glucose data to Dexcom Clarity via a compatible smart device: dexcom.com\/compatibility. Healthcare providers will only be able to view a patient\u2019s glucose data if the patient elects to share it with them through Dexcom Clarity.<\/p>\n<p>\n|| Separate Dexcom Follow app and internet connection required. Users should always confirm readings on the Dexcom G7 app or receiver before making treatment decisions.<\/p>\n<p>\n1 Garg SK, et al.<i> Diabetes Technol Ther<\/i>. 2025;27(6):413-502.<\/p>\n<p>\n2 Dexcom G7 15 Day User Guide.<\/p>\n<p>\n3 FreeStyle Libre 3+ User Manual.<\/p>\n<p>\n4 Medtronic Guardian Sensor User Guide.<\/p>\n<p>\n5 Dexcom, Data on File, 2025.<\/p>\n<p>\n6 Beck RW, et al<i>. JAMA.<\/i> 2017;317(4):371-378.<\/p>\n<p>\n7 Beck RW, et al<i>. Ann Intern Med<\/i>. 2017;167(6):365-374.<\/p>\n<p>\n8 Martens T, et al.<i> JAMA.<\/i> 2021;325(22):2262-2272.<\/p>\n<p>\n9 Laffel LM, et al.<i> JAMA.<\/i> 2020;323(23):2388-2396.<\/p>\n<p>\n10 Welsh JB, et al<i>. J Diabetes Sci Technol.<\/i> 2024;18(1):143-147.<\/p>\n<p>\n11 Diabetes Canada. Diabetes in Canada. <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diabetes.ca%2Fadvocacy-policies%2Fadvocacy-reports%2Fnational-and-provincial-backgrounders%2Fdiabetes-in-canada&amp;esheet=54569642&amp;newsitemid=20260713940133&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.diabetes.ca%2Fadvocacy-policies%2Fadvocacy-reports%2Fnational-and-provincial-backgrounders%2Fdiabetes-in-canada&amp;index=3&amp;md5=8037ac35fef8d210884d51c5babbc2c8\">https:\/\/www.diabetes.ca\/advocacy-policies\/advocacy-reports\/national-and-provincial-backgrounders\/diabetes-in-canada<\/a>. Accessed May 7, 2026.<\/p>\n<p>\n12 Polonsky WH, Fortmann AL. <i>Diabetes Technol Ther<\/i>. 2021;23(3):195-202.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260713940133r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260713940133\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260713940133\/en\/<\/a><\/span><\/p>\n<p><b>Investor Contact:<br \/>\n<\/b><br \/>Sean Christensen<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:sean.christensen@dexcom.com\">sean.christensen@dexcom.com<\/a><\/p>\n<p><b>Media Contact:<br \/>\n<\/b><br \/>Kyla Rudyk-de Leth<br \/>\n<br \/>Veritas Communications<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:rudyk@veritasinc.com\">rudyk@veritasinc.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> North America Canada<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Diabetes Medical Devices Health Medical Supplies<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Photo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260713940133\/en\/2850555\/3\/25.05.26_Dexcom_Day_030483_V2_%281%29.jpg\" alt=\"Photo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\">Dexcom G7 15 Day receives Health Canada authorization. Compatible smart devices sold separately. For a list of compatible devices, see dexcom.com\/compatibility.<\/font><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260713940133\/en\/1474219\/3\/New_Dexcom_Logo.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes Dexcom G7 15 Day is the longest\u2011lasting and most accurate1-4 CGM system authorized by Health Canada, providing real-time glucose readings for an industry-leading 15.5 days5. BURNABY, British Columbia&#8211;(BUSINESS WIRE)&#8211; Dexcom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) for people 18 years and older living with diabetes. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20260713940133\/en\/ Dexcom G7 15 Day receives Health Canada authorization. Compatible smart devices sold separately. For a list of compatible devices, see dexcom.com\/compatibility. Dexcom G7 15 Day is &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-981153","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes Dexcom G7 15 Day is the longest\u2011lasting and most accurate1-4 CGM system authorized by Health Canada, providing real-time glucose readings for an industry-leading 15.5 days5. BURNABY, British Columbia&#8211;(BUSINESS WIRE)&#8211; Dexcom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) for people 18 years and older living with diabetes. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20260713940133\/en\/ Dexcom G7 15 Day receives Health Canada authorization. Compatible smart devices sold separately. For a list of compatible devices, see dexcom.com\/compatibility. Dexcom G7 15 Day is &hellip; Continue reading &quot;Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-13T20:49:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260713940133\/en\/2850555\/4\/25.05.26_Dexcom_Day_030483_V2_%281%29.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes\",\"datePublished\":\"2026-07-13T20:49:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\\\/\"},\"wordCount\":845,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260713940133\\\/en\\\/2850555\\\/4\\\/25.05.26_Dexcom_Day_030483_V2_%281%29.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\\\/\",\"name\":\"Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260713940133\\\/en\\\/2850555\\\/4\\\/25.05.26_Dexcom_Day_030483_V2_%281%29.jpg\",\"datePublished\":\"2026-07-13T20:49:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260713940133\\\/en\\\/2850555\\\/4\\\/25.05.26_Dexcom_Day_030483_V2_%281%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260713940133\\\/en\\\/2850555\\\/4\\\/25.05.26_Dexcom_Day_030483_V2_%281%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\/","og_locale":"en_US","og_type":"article","og_title":"Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes - Market Newsdesk","og_description":"Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes Dexcom G7 15 Day is the longest\u2011lasting and most accurate1-4 CGM system authorized by Health Canada, providing real-time glucose readings for an industry-leading 15.5 days5. BURNABY, British Columbia&#8211;(BUSINESS WIRE)&#8211; Dexcom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) for people 18 years and older living with diabetes. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20260713940133\/en\/ Dexcom G7 15 Day receives Health Canada authorization. Compatible smart devices sold separately. For a list of compatible devices, see dexcom.com\/compatibility. Dexcom G7 15 Day is &hellip; Continue reading \"Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\/","og_site_name":"Market Newsdesk","article_published_time":"2026-07-13T20:49:07+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260713940133\/en\/2850555\/4\/25.05.26_Dexcom_Day_030483_V2_%281%29.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes","datePublished":"2026-07-13T20:49:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\/"},"wordCount":845,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260713940133\/en\/2850555\/4\/25.05.26_Dexcom_Day_030483_V2_%281%29.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\/","name":"Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260713940133\/en\/2850555\/4\/25.05.26_Dexcom_Day_030483_V2_%281%29.jpg","datePublished":"2026-07-13T20:49:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260713940133\/en\/2850555\/4\/25.05.26_Dexcom_Day_030483_V2_%281%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260713940133\/en\/2850555\/4\/25.05.26_Dexcom_Day_030483_V2_%281%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-g7-15-day-receives-health-canada-authorization-extending-wear-and-continuity-for-canadian-adults-living-with-diabetes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/981153","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=981153"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/981153\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=981153"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=981153"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=981153"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}